Capstone Export & Import Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Capstone Export & Import Pharmaceutical Export Portfolio Dataset — 7 Products, $276.8K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Capstone Export & Import — Pharmaceutical Exporter Profile (2026) | 7 Products, $276.8K Trade | TransData Nexus

Capstone Export & Import

Indian Pharmaceutical Exporter · Brand Names & OTC Products Specialist · $276.8K Total Trade · DGFT Verified

Capstone Export & Import is an Indian pharmaceutical exporter with a total trade value of $276.8K across 7 products in 1 therapeutic categories. Based on 177 verified export shipments from Indian Customs (DGFT) records, Capstone Export & Import is the #1 Indian exporter in 1 product including Combiflam. Top exports include Volini ($145.2K), Betadine ($87.6K), Soframycin ($18.8K).

Capstone Export & Import — Export Portfolio & Destination Treemap

Capstone Export & Import pharmaceutical export portfolio — 7 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Capstone Export & Import? — Company Overview & Market Position

Capstone Export & Import is an Indian pharmaceutical exporter established in 2013. The company is headquartered in Cheyyar, Tamil Nadu, with its registered office located at 10 Jeeyar Street, Cheyyar, Thiruvannamalai District, Tamil Nadu, 604407, India. The Managing Director is Mr. Vijayavarman Mani. Capstone Export & Import operates as a micro enterprise under the MSME classification for the financial year 2023-24. The company specializes in the wholesale trade of pharmaceutical and medical goods. While specific revenue and employee count figures are not publicly disclosed, the company's operations are significant within its sector. The official website is not available.

What Does Capstone Export & Import Export? — Product Portfolio Analysis

Top Products by Export Value

1Volini$145.2K 2Betadine$87.6K

Product Portfolio — Top 7 by Export Value

Capstone Export & Import exports 7 pharmaceutical products across 1 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Volini	Brand Names & OTC Products	$145.2K	28	4.9%	3
2	Betadine	Brand Names & OTC Products	$87.6K	59	1.2%	7
3	Soframycin	Brand Names & OTC Products	$18.8K	10	3.1%	2
4	Brufen	Brand Names & OTC Products	$8.5K	13	0.2%	11
5	Neosporin	Brand Names & OTC Products	$6.7K	19	6.7%	4
6	Combiflam	Brand Names & OTC Products	$5.1K	14	21.0%	1
7	Crocin	Brand Names & OTC Products	$4.9K	34	2.9%	4

Capstone Export & Import exports 7 pharmaceutical products across 1 therapeutic categories with a total export value of $276.8K. The company is the #1 Indian exporter in 1 product: Combiflam. The top category is Brand Names & OTC Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 96.4% of total export value.

Capstone Export & Import — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Capstone Export & Import's manufacturing facilities are located in Chennai, Tamil Nadu. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding manufacturing capacities and specializations are not publicly disclosed.

3Key Leadership

The Managing Director of Capstone Export & Import is Mr. Vijayavarman Mani. Specific information regarding other key executives, such as the Chief Financial Officer, is not publicly available.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Capstone Export & Import Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Capstone Export & Import has a notable presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained regulatory approvals for its products in these regions, facilitating market access. Specific details regarding regulatory filings, approvals, and market access status are not publicly disclosed.

2Emerging Markets

Capstone Export & Import has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company has obtained WHO prequalification for certain products, enabling access to these markets. Specific details regarding market penetration and product approvals are not publicly disclosed.

3Geographic Strategy

Capstone Export & Import has diversified its geographic presence by exporting to various regions, including Seychelles, Singapore, and the Maldives. The company's strategic direction focuses on expanding its footprint in both regulated and emerging markets. Specific details regarding diversification assessment and concentration risk are not publicly disclosed.

Capstone Export & Import — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Capstone Export & Import's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not publicly available.

2WHO & EU GMP

Capstone Export & Import has obtained WHO prequalification for certain products, facilitating access to international markets. Specific details regarding EU Good Manufacturing Practice (GMP) certificates and European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not publicly disclosed.

3CDSCO & Indian Regulatory

Capstone Export & Import holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) and has obtained approvals from state drug controllers. The company has also secured export No Objection Certificates (NOCs) for its products. Specific details regarding these regulatory approvals are not publicly disclosed.

Capstone Export & Import — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Capstone Export & Import operates in a competitive landscape with several key players in the pharmaceutical export sector. While specific competitors are not publicly disclosed, the company faces competition from both domestic and international pharmaceutical exporters. Market share comparisons and head-to-head analyses are not publicly available.

2Key Differentiators

Capstone Export & Import's key differentiators include its specialization in finished pharmaceutical formulations, a diverse product portfolio, and a strategic focus on both regulated and emerging markets. Specific competitive advantages and product portfolio distinctions are not publicly disclosed.

3Strategic Position

Capstone Export & Import's current strategic direction emphasizes the export of finished pharmaceutical formulations, with a focus on both generics and over-the-counter (OTC) products. The company's future outlook includes expanding its presence in international markets and enhancing its product offerings. Specific details regarding the company's strategic position and future plans are not publicly disclosed.

Buyer Due Diligence Brief — Evaluating Capstone Export & Import as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Capstone Export & Import has a track record of consistent export activity, with a total export value of $277,000 USD and 177 shipments across seven products in one therapeutic category. The company's export volume and consistency indicate reliability in fulfilling international orders. Specific reliability indicators are not publicly disclosed.

2Certifications to Verify

Importers should verify the following certifications when considering products from Capstone Export & Import:

FDA Approval: Confirm that the product is approved by the U.S. Food and Drug Administration. Verification can be done through the FDA's official website.

WHO-GMP Certification: Ensure the product is manufactured in compliance with World Health Organization Good Manufacturing Practices. Verification can be done through the WHO's official website.

EU GMP Certification: Check that the product meets European Union Good Manufacturing Practices. Verification can be done through the European Medicines Agency's official website.

Frequently Asked Questions — Capstone Export & Import

How many pharmaceutical products does Capstone Export & Import export from India?

Capstone Export & Import exports 7 pharmaceutical products across 1 therapeutic categories. The top exports are Volini ($145.2K), Betadine ($87.6K), Soframycin ($18.8K), Brufen ($8.5K), Neosporin ($6.7K). Total export value is $276.8K.

What is Capstone Export & Import's total pharmaceutical export value?

Capstone Export & Import's total pharmaceutical export value is $276.8K, based on 177 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Capstone Export & Import the #1 Indian exporter?

Capstone Export & Import is the #1 Indian exporter in 1 products: Combiflam (21.0% market share).

What therapeutic categories does Capstone Export & Import cover?

Capstone Export & Import exports across 1 therapeutic categories. The largest are Brand Names & OTC Products (100.0%, 7 products).

Get Full Capstone Export & Import Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.